comparemela.com
Home
Live Updates
Antengene Announces Latest Clinical Trial Data of ATG-008 (onatasertib) to be presented in the upcoming 2022 American Society of Clinical Oncology Annual Meeting : comparemela.com
Antengene Announces Latest Clinical Trial Data of ATG-008 (onatasertib) to be presented in the upcoming 2022 American Society of Clinical Oncology Annual Meeting
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering,...
Related Keywords
Australia ,
Shanghai ,
China ,
United States ,
Hong Kong ,
Singapore ,
Beijing ,
Illinois ,
South Korea ,
Chicago ,
American ,
Kevin Lynch ,
Asia Pacific ,
Peter Qian ,
American Society Of Clinical Oncology Annual Meeting ,
Company Annual ,
Antengene Corporation ,
Hong Kong Stock Exchange ,
Antengene Corporation Limited ,
Clinical Oncology Annual Meeting ,
Chief Medical ,
Beijing Time ,
Corporation Limited ,
Patients Beyond ,
Asia Pacific Region ,
Greater China ,
Annual Report ,
Hong Kong Stock ,
comparemela.com © 2020. All Rights Reserved.